FOS and cancer: These studies revealed that multiple signaling pathways, transcription factors, and microRNAs, such as the Raf-MEK-ERK signaling pathway, transcription factor AP-1, and nuclear factor κB (NF-κB) could regulate TF expression in cancer cells [70].